PATENT CLAIM ANALYSIS

Application Number: 16257784
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["435", "183000"]

Abstract:
The present invention relates to polymerase HBV mutant polypeptides comprising a mutated polymerase domain which is functionally disrupted for polymerase activity and fusion proteins comprising such polymerase mutant polypeptide. The present invention also relates to a nucleic acid molecule and an expression vector for expressing said polymerase mutant polypeptide as well as a composition which can be used for eliciting an immune response to HBV with the goal of providing a protective or therapeutic effect against HBV infection.

Claim (Index 89):
The method according to  claim 68 , which is carried out according to prime boost modality.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 99.0
- Lexical Diversity: 1.48148
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14232082', '15369118', '13423193', '13388826', '13037931']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7282670497391223
- 35 USC 102 Novelty (BERT): 0.6196423573447252
- Combined Prediction Score: 0.7174045804996826
- Mean Citation Score: 607.8404679999999
- Max Citation Score: 773.92725
- Similarity Product: 485.30716785666345

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test